Ema M, Amano H, Ogawa Y
National Institute of Health Sciences, Osaka Branch, Japan.
Toxicology. 1994 Feb 7;86(3):163-74. doi: 10.1016/0300-483x(94)90002-7.
The objective of this study was to determine the characterization of the developmental toxicity of di-n-butyl phthalate (DBP) in rats. Pregnant rats were given DBP by gastric intubation at a dose of 0.75, 1.0 or 1.5 g/kg on days 7-9, 10-12 or 13-15 of pregnancy. Postimplantation loss was 100% for each period of dosing at 1.5 g/kg. A significant increase in the postimplantation loss was found in dams given DBP at doses of 0.75 and 1.0 g/kg regardless of the days of treatment. No evidence of teratogenicity was detected when DBP was given on days 10-12. Treatment on days 7-9 with DBP at doses of 0.75 and 1.0 g/kg caused a significant increase in the number of skeletal malformations such as deformity of the vertebral column in the cervical and thoracic regions and of the ribs, but neither external nor internal malformations. Treatment with DBP on days 13-15 at doses of 0.75 and 1.0 g/kg resulted in a significant increase in the incidence of fetuses with external and skeletal malformations such as cleft palate and fusion of the sternebrae. The frequency of malformations increased as the dose of DBP was increased. The highest incidence of malformed fetuses occurred after treatment with DBP on days 13-15. It could be concluded that susceptibility to the teratogenicity of DBP varies with the developmental stage at the time of administration.
本研究的目的是确定邻苯二甲酸二丁酯(DBP)对大鼠发育毒性的特征。在妊娠第7至9天、10至12天或13至15天,通过胃管给怀孕大鼠灌胃DBP,剂量分别为0.75、1.0或1.5 g/kg。在1.5 g/kg剂量下,每个给药期的着床后丢失率均为100%。无论治疗天数如何,在给予0.75和1.0 g/kg剂量DBP的母鼠中,着床后丢失率均显著增加。在第10至12天给予DBP时,未检测到致畸性证据。在第7至9天用0.75和1.0 g/kg剂量的DBP治疗,导致骨骼畸形数量显著增加,如颈椎和胸椎区域的脊柱畸形以及肋骨畸形,但未出现外部或内部畸形。在第13至15天用0.75和1.0 g/kg剂量的DBP治疗,导致出现外部和骨骼畸形(如腭裂和胸骨融合)的胎儿发生率显著增加。畸形频率随DBP剂量增加而增加。畸形胎儿的最高发生率出现在第13至15天用DBP治疗后。可以得出结论,DBP致畸性的易感性随给药时的发育阶段而变化。